World Obesity Day | China's Innovative Gastric Bypass Stent System Aids Global Obesity Prevention and Treatment with High-Quality Weight Loss

March 4th is World Obesity Day. This year, the theme is "8 Billion Reasons to Act on Obesity", calling on the entire world to take action together to address obesity.

In this context, Xinhuanet jointly launched a special initiative called "World Obesity Day" with Tongee Medical. We invited authoritative experts in the field of weight loss from both home and abroad to jointly explore scientific weight loss methods and share the global application of China's original endoscopic weight loss technology - the gastric bypass stent system. This initiative aims to contribute Chinese wisdom and solutions to global obesity prevention and treatment.

Beyond Reducing Numbers, Enhancing Quality

Obesity is a chronic disease that requires standardized diagnosis and treatment. It not only causes metabolic problems such as high blood lipid, high blood sugar, and high uric acid, but also becomes a risk factor for major diseases like tumors. The core of scientific weight loss has long gone beyond simply reducing body weight, and has shifted towards improving metabolism, reducing visceral fat, and achieving a high-quality weight loss goal of fat loss and muscle gain.

Li Wen, the director of the Gastroenterology Department at Beijing United Family Healthcare, pointed out that the development of obesity is a continuous pathological process. If not intervened in time at an early stage， it will progress from being overweight to moderate to severe obesity, and eventually lose the ability to control oneself, falling into a vicious cycle of "the fatter one becomes, the less able to move； the less able to move one becomes， the fatter one gets". Therefore， scientific weight loss should not only focus on early self-management， but also adopt standardized medical intervention during the disease stage， always taking overall health improvement as the core, rather than simply pursuing weight loss.

Endoscopic Weight Loss: A Breakthrough Reshaping Treatment Pathways

In traditional obesity treatment, patients with moderate to severe obesity have long faced a "high barrier" problem: lifestyle interventions and drug treatments often have limited effects, while surgical procedures, due to their invasive nature and irreversibility, have deterred many people. In recent years, the rapid development of endoscopic weight loss technologies has filled in the crucial link in the stepped treatment for obesity, providing better options for patients with moderate to severe obesity.

Wang Qijin, the director of the Medical Affairs Department and Endocrinology Department of Shanghai International Medical Center, pointed out that the endoscopic weight loss technology has promoted the diagnosis and treatment of moderate to severe obesity towards a more precise and minimally invasive direction. Taking the gastric bypass stent system as an example, it not only reshaped the treatment path for obesity but also effectively promoted the concept of achieving treatment goals, helping patients achieve weight loss and metabolic improvement earlier and gaining valuable time for subsequent health management.

At the same time, Li Wen also stated that technological advancements have led to an upgrade in our understanding of diseases. Previously, many patients chose surgical procedures out of ignorance of the "no-gastric-resection" weight loss method. The core of endoscopic weight loss technology lies in returning to the disease itself, achieving the greatest health benefits with minimal trauma. This is the best embodiment of the patient-centered medical treatment concept.

Chinese Innovation Leads the Way, Technology Export Benefits Global Patients

As the core therapy in the field of endoscopic weight loss, the domestically developed gastric bypass stent system in China provides a valuable means of "fat reduction and muscle gain" for weight loss treatment. It enables high-quality weight loss to become the norm in clinical practice and also enables Chinese original medical technology to occupy an important position in the global obesity prevention and treatment field.

At present, the gastric bypass stent system has been widely applied on a large scale in China and has been recognized by many international experts. It has successfully been implemented in clinical practice in countries such as Indonesia. Dr. Reno Rudiman, the president of the Indonesian Society of Metabolism and Obesity, highly affirmed the diagnostic and therapeutic value of this system for obese patients in Southeast Asia. He believed that it provides a safe, reversible and economically efficient innovative method for weight loss treatment in the local area, significantly lowering the treatment threshold for patients and greatly enhancing confidence in promoting the wide application of this technology in Indonesia in the future.

Inbound Medical Tourism Highlights China's Healthcare Capabilities

The efficiency of Chinese medical care and the reasonable cost of treatment have always been significant advantages that attract overseas patients to seek medical treatment in China. With the internationalization of China's original-developed endoscopic weight loss technologies such as the gastric bypass stent system, China's international recognition as a global hub for weight loss and metabolic disease diagnosis and treatment has continued to rise. Many overseas obese patients come here in search of high-quality weight loss solutions.

Li Wen once treated a British patient with extremely severe obesity. Not only did the gastric bypass stent system precisely meet the patient's core demand of "no surgery", but the comprehensive commercial insurance coverage and the entire process of service also relieved the patient's worries. The entire treatment process only took 25 to 30 minutes, and the patient fully adapted within 1 to 2 days after the surgery. The patient was excitedly expressing, "This is exactly the minimally invasive treatment I wanted!" 。

Li Wen emphasized that, guided by the vision of a shared future for humanity, China's original endoscopic weight loss technology, using clinical effectiveness as a bridge, is accelerating the breaking down of geographical and cultural barriers and bringing health benefits to the entire world. The medical visits of overseas patients to China have also become an important link in the medical exchanges between China and foreign countries, promoting the sharing of experience and technical collaboration in the field of global obesity prevention and treatment.

This special initiative for "World Obesity Day" is not only a positive response to the global call for prevention and control of obesity, but also a vivid demonstration of China's original medical technology contributing to global public health. In the future, Tongee Medical will continue to focus on its independent innovation technology and work hand in hand with countries around the world to promote the establishment of a more efficient, safer and more inclusive obesity prevention and treatment system.